Levolin 0.31mg Respules

Introduction

Levolin is a prescription medication that contains the active ingredient Levosalbutamol. It is available in the form of a respule and is primarily used for the treatment of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD).

Uses

Levolin is prescribed to relieve symptoms associated with conditions such as asthma and COPD. It helps to open up the airways, making it easier to breathe and reducing symptoms such as wheezing, coughing, and shortness of breath.

Dosage and Administration

The dosage of Levolin may vary depending on the individual’s condition and response to treatment. Follow the instructions provided by your healthcare professional. Typically, the medication is administered through a nebulizer or inhaler device. The recommended dose for adults and children above 12 years of age is usually 1 to 2 respules (1 respule = 2.5 mg) taken 3 to 4 times a day. However, the dosage may be adjusted based on the severity of the symptoms and the individual’s response to treatment.

Mechanism of Action

Levosalbutamol, the active ingredient in Levolin, belongs to a class of medications called bronchodilators. It works by relaxing the muscles in the airways, thereby widening them and allowing for easier airflow. This helps to relieve bronchospasm, which is the narrowing of the airways that occurs in conditions such as asthma and COPD.

Side Effects

Common side effects may include headache, tremor, nervousness, palpitations, and muscle cramps. These side effects are usually mild and temporary. However, if any of these side effects persist or worsen, seek medical attention.

In rare cases, Levolin may cause serious side effects such as chest pain, rapid heartbeat, worsening breathing difficulties, or allergic reactions. If you experience any of these serious side effects, seek immediate medical attention.

Drug Interactions

inform your healthcare professional about all the medications you are currently taking, including prescription, over-the-counter, and herbal products. Some medications may interact with Levolin and affect its effectiveness or increase the risk of side effects. Common drug interactions may include beta-blockers, diuretics, and other bronchodilators. Your healthcare professional will be able to provide you with more information on potential drug interactions.

Precautions

Before using Levolin, inform your healthcare professional about any existing medical conditions or allergies you may have. This medication may not be suitable for everyone, especially individuals with certain heart conditions or a history of hypersensitivity to Levosalbutamol.

Levolin should be used with caution in individuals with diabetes, high blood pressure, or thyroid disorders. Follow your healthcare professional’s recommendations and monitor your condition closely while using this medication.

Storage

Patient Tips

• Follow the prescribed dosage and administration instructions provided by your healthcare professional.
• If you experience any new or worsening symptoms while using Levolin, inform your healthcare professional.
• Keep track of your medication supply and refill it in a timely manner to ensure continuity of treatment.
• If you have any questions or concerns about Levolin, consult your healthcare professional for further guidance.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Levosalbutamol (International database) (Drugs.com) [Accessed 27 Jun. 2024] (online) Available at:
• Ormrod D, Spencer CM. Levosalbutamol. BioDrugs. 1999 Jun;11(6):431-8. doi: 10.2165/00063030-199911060-00007. [Accessed 29 Jun. 2024] Available at:
• Punj A, Prakash A, Bhasin A. Levosalbutamol vs racemic salbutamol in the treatment of acute exacerbation of asthma. Indian J Pediatr. 2009 Nov;76(11):1131-5. doi: 10.1007/s12098-009-0245-4. [Accessed 2 Jun. 2024] Available at:
• [No authors listed] Levalbuterol. 2024 May 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. [Accessed 24 Jun. 2024] Available at: